Search

everythinglearnresearchcommunity

for

Search:↓

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

Intralesional cidofovir may be a viable alternative treatment for SCC.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

CAP7.1 is generally safe at 200 mg/m²/day, but can cause fatigue, nausea, hair loss, fever, and blood-related issues.

Mycophenolate mofetil is safer and more effective than cyclophosphamide for treating lupus nephritis.

Fosravuconazole effectively treated a woman's scalp infection without side effects.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Sorafenib may cause hand-foot and stump syndrome, requiring early detection and management.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Blocking S100A8 can reduce chemotherapy-induced hair loss.

Itraconazole-loaded nanoparticles are more effective and less toxic for treating fungal infections than conventional oral itraconazole.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

Human hair follicle stem cells improve ovarian function in mice with damaged ovaries.

New strategies like vitamin A and dextromethorphan can help reduce methotrexate side effects and improve patient adherence.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

Effective treatment for UFT overdose includes antibiotics and G-CSF, with bone marrow biopsy and transfusion as backup options.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Sulphadiazine can cause crystals to form in urine.